FAS plays a critical role in hepatic lipogenesis and it was estimated that approximately 26% of the fat in the liver is from de novo lipogenesis in NAFLD patients [39]. The gene discussed is FAS; the disease is metabolic dysfunction-associated steatotic liver disease.